Most recently, Bill was the Chief Financial Officer of Aerin Medical Inc., which makes products to treat chronic nasal conditions non-invasively.

Prior to Aerin, Bill spent 13 years as CFO and Executive VP of Finance for On-X Life Technologies, Inc., a heart surgery medical device company which was sold to Artvivion (CryoLife) in 2016.

Early in his career, Bill spent nine years specializing in healthcare with the public accounting firm PriceWaterhouseCoopers (formerly Price Waterhouse) followed by executive management positions with PhyCor, Inc., Physicians Trust, Inc., US Orthopedics, Inc., and Acxiom Corporation.

Bill served on the boards of directors of Apollo Endosurgery Inc. and Reata Pharmaceuticals Inc, both publicly-traded companies, and chaired their Audit Committees until their acquisitions by Boston Scientific and Biogen, respectively. Bill has also served on numerous other boards of directors or advisory boards including public, private, non-profit and private equity/venture capital.